实用医学杂志 ›› 2022, Vol. 38 ›› Issue (16): 2066-2070.doi: 10.3969/j.issn.1006⁃5725.2022.16.016

• 临床研究 • 上一篇    下一篇

抗氧化联合常规治疗对重型颅脑损伤合并肺部感染患者的疗效

王晓霞1,3 骆建军1 邓勇2 方向明3    

  1. 中国人民解放军联勤保障部队第九〇三医院1 重症医学科(战创伤急救中心); 2 神经外科(杭州 310000);3 浙江大学医学院(杭州 310011);

  • 出版日期:2022-08-25 发布日期:2022-08-25
  • 通讯作者: 骆建军 E⁃mail:luojianjun4567@126.com
  • 基金资助:
    2020 年度杭州市卫生科技计划项目支持(编号:B20200452)

Efficacy of antioxidant combined with conventional therapy in patients with severe craniocerebral injury complicated with pulmonary infection

WANG Xiaoxia*,LUO Jianjun,DENG Yong,FANG Xiangming.   

  1. Department of Critical Care Medicine(War Trauma Emergency Center),No. 903 Hospital,Joint Logistics Support Force of the Chinese People′s Liberation Army,Hangzhou 310000,China;*Zhejiang University School of Medicine Hangzhou 310011,China 

  • Online:2022-08-25 Published:2022-08-25
  • Contact: LUO Jianjun E⁃mail:luojianjun4567@126.com

摘要:

目的 观察抗氧化治疗对于重型颅脑损伤合并细菌性肺炎患者疗效指标的变化。方法 前瞻性选择 2020 2 月至 2022 2 月收治我院的重型颅脑损伤并发肺部感染患者 87 例,均由患者家属知 情同意后,采用就诊顺序的单双号随机分为对照组与观察组。对照组(45 例)采取常规基础治疗,观察组 42 例)在常规治疗基础上联合抗氧化治疗,连续治疗 7 d,观察并记录治疗前后的白细胞(WBC)、超敏反 应蛋白(CPR)、中性粒细胞(NEUT)等炎症指标;血酸碱度(pH)、动脉血氧饱和度(SaO2)、氧合指数(P/F)、 动脉血二氧化碳分压(PaCO2)等肺部通气量指标;丙二醛(MDA)、超氧化物歧化酶(SOD)、过氧化脂 质(LPO)、抗氧化能力(TAOC)、髓过氧化物酶(MPO)等氧化应激指标;格拉斯哥昏迷指数(GCS)评分。 结果 两组治疗前 GCS 评分、血气指标、氧化应激水平、急性感染生化指标差异无统计学意义(P > 0.05)。两组各自治疗前后比较,差异有统计学意义(P < 0.01)。治疗 1 周后观察组 WBC、CPR、NEUT、Pa⁃ CO2、MPO、LPO 均低于对照组(P < 0.01),pH、SaO2、P/F、SOD、MDA 水平及 GCS 评分均明显高于对照组 P < 0.01),TAOC 水平亦显著高于对照组(P < 0.05)。结论 临床对于颅脑损伤合并肺部感染患者联合 抗氧化药物能有效改善患者炎症指标以及颅脑损伤指标;对于肺部感染以及颅脑损伤均有显著获益,临床值得推广。

关键词:

重型颅脑损伤, 肺部感染, 合并症, 抗氧化治疗, 临床疗效

Abstract:

Objective To observe the changes of curative effect indexes of antioxidant therapy in patients with severe craniocerebral injury complicated with bacterial pneumonia. Methods A total of 87 patients with severe craniocerebral injury complicated by pulmonary infection who were admitted to our hospital from February 2020 to February 2022 were prospectively selected. With the informed consent of the patient′s family members,they were randomly divided into control group(n = 45)and observation group(n = 42)according to the odd and even num⁃ bers of the visiting order. The control group was given routine treatment,and the observation group antioxidant therapy on the basis of conventional treatment for 7 consecutive days. WBC,CPR,neutrophil,cell(NEUT)and other inflammatory indicators;blood pH(pH),arterial oxygen saturation(SaO2),oxygenation index(P/F),arterial blood carbon dioxide partial pressure(PaCO2)and other pulmonary ventilation oxidative stress indicators;malondi⁃ aldehyde(MDA),superoxide dismutase(SOD),lipid peroxide(LPO),antioxidant capacity(TAOC),myeloper⁃ oxidase(MPO)and other oxidative stress indicators;and Glasgow coma index(GCS)score before and after the treatment in the two groups were recorded and compared. Results There was no significant difference in GCS score,blood gas index,oxidative stress level and acute infection biochemical index between the two groups before treatment(P > 0.05). There were statistically significant differences in the two groups before and after the treat⁃ ment(P < 0.01). WBC,CPR,NEUT,PaCO2,MPO,and LPO in the observation group were lower than those inthe control group(P < 0.01),and the level of pH,SaO2,P/F,SOD,MDA and GCS was significantly higher(P < 0.01). The level of TAOC was also significantly higher than that of the control group(P < 0.05)after 1 week of treatment. Conclusion The combination of antioxidant drugs in patients with craniocerebral injury and pulmonary infection can effectively improve inflammatory indexes and craniocerebral injury indexes of patients,which has sig⁃ nificant benefits for pulmonary infection and craniocerebral injury,and it is worthy of clinical promotion.

Key words:

severe craniocerebral injury, pulmonary infection, comorbidity, antioxidant, clinical efficacy